Ovarian Cancer Clinical Trials in New York State

Showing 201-201 of 201 trials

Clinical Trial for Ovarian Cancer (OvaRex®)

NCT00050375

This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.

Ovarian Cancer

Unither Pharmaceuticals354 participantsStarted Dec 2002

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +59 more locations

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer Trials in Other Cities

Other Conditions in New York State